Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FCB41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,386
Award facts
- Contract value 100% obligated
- $12,385.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $12,385.69, was awarded on January 21, 2026, to AmerisourceBergen Drug Corp by the Defense Logistics Agency, a Department of Defense component. The contract is a firm fixed-price award with no set-aside designation, indicating competitive selection. The performance location is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031. This prime IDC vehicle enables the delivery of comprehensive pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems under the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical commodities across multiple therapeutic domains, from diabetes medications to neurological treatments and pain management pharmaceuticals. The ultimate completion date for this delivery order is January 22, 2026, reflecting the time-limited nature of this specific task order drawn from the larger pharmaceutical prime vendor contract vehicle.
Quick answers
Who was awarded contract SPE2DU26FCB41?
SPE2DU26FCB41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DU26FCB41 worth?
The government has obligated $12,386 on SPE2DU26FCB41.
Is contract SPE2DU26FCB41 an order under another contract?
Yes. SPE2DU26FCB41 is a delivery order under SPE2DU25D1219, an indefinite delivery contract.
Was contract SPE2DU26FCB41 competed?
The extent of competition for SPE2DU26FCB41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award